Showing results (271-280 of 7,002) with videos related to
Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|September 18, 2002
The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancerS M Keller, M G Vangel, S Adak, et al.Lung Cancer (Amsterdam, Netherlands)|August 21, 2003
The changing epidemiology of lung cancer in EuropeMaryska L G Janssen-Heijnen, Jan-Willem W CoeberghLung Cancer (Amsterdam, Netherlands)|August 21, 2003
Genetic susceptibility and dietary patterns in lung cancerYa-Yu Tsai, Katherine A McGlynn, Ying Hu, et al.Lung Cancer (Amsterdam, Netherlands)|August 21, 2003
Histopathological evaluation of fluorescence bronchoscopy using resected lungs in cases of lung cancerNorihiko Ikeda, Toshimitsu Hiyoshi, Masatoshi Kakihana, et al.Lung Cancer (Amsterdam, Netherlands)|August 21, 2003
Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trialPetr Zatloukal, Lubos Petruzelka, Milada Zemanová, et al.Lung Cancer (Amsterdam, Netherlands)|August 21, 2003
Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathyMarina S Savchenko, Alexandr V Bazhin, Olga N Shifrina, et al.Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Targeted therapies for stage III non-small cell lung cancer: integration in the combined modality settingEverett E Vokes, Hak ChoyLung Cancer (Amsterdam, Netherlands)|July 18, 2003
Targeted molecular mechanisms of epoetin alfaCorey J Langer, Fred R Hirsch, Hernan Cortés-Funes, et al.Lung Cancer (Amsterdam, Netherlands)|July 23, 2003
The effect of adenovirus-IkappaBalpha transduction on the chemosensitivity of lung cancer cell line with resistance to cis-diamminedichloroplatinum(II)(cisplatin) and doxorubicin(adriamycin)Choon-Taek Lee, Ja Young Seol, Seok Young Lee, et al.Lung Cancer (Amsterdam, Netherlands)|July 23, 2003
1st International Lung Cancer Conference in Beijing, October 27-30, 2002David M Jablons, Shu-Jun Cheng, R N Carolyn Clary-Macy, et al.Pageof 701